ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Search result - IPro for Recombinate
Information for professionals for Recombinate:Apotheke im Freihof
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
Registration ownerLast update of information 
B02BD02 - Coagulation Factor ViiiATC-DDD Version 2016. Source: WHO
B - Blood and Blood Forming Organs
 
B02 - Antihemorrhagics
 
B02B - Vitamin K and Other Hemostatics
 

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).

B02BD - Blood Coagulation Factors

This group comprises all blood coagulation factors, thrombin etc., incl. preparations for local use, and their combinations. Gene therapy products replacing coagulation factors are also classified in this group.
For systemic formulations of fibrinogen (factor I), see - B02BB - Fibrinogen.
Prothrombin complexes containg three or all four factors are classified in B02BD01 coagulation factor IX, II, VII and X.
Both human derived and recombinant factor VIII and factor IX products will be classified in B02BD02 - coagulation factor VIII and B02BD04 - coagulation factor IX, respectively.

No DDDs are established for blood coagulation factors. The use of blood coagulation factors could be measured in blood factor units (IU).

B02BD02 - Coagulation Factor Viii
 
ATC-Browser | Drugs A-Z | Recent Registrations
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home